- decreased bone mineral density / IMPC
- increased circulating calcium level / IMPC
- decreased circulating phosphate level / IMPC
- decreased hematocrit / IMPC
- increased startle reflex / IMPC
- decreased mean corpuscular volume / IMPC
- decreased circulating triglyceride level / IMPC
- decreased hemoglobin content / IMPC
- increased circulating alanine transaminase level / IMPC
- abnormal behavior / IMPC
- decreased circulating amylase level / IMPC
- increased bone mineral content / IMPC
C57BL/6NTac-Gna11tm1a(EUCOMM)Wtsi/Cnrm
Status | Available to order |
EMMA ID | EM:04385 |
International strain name | C57BL/6NTac-Gna11tm1a(EUCOMM)Wtsi/Cnrm |
Alternative name | EPD0156_3_A04 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Gna11tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Gna11 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | CNR, Consiglio Nazionale delle Ricerche |
Provider affiliation | EMMA-Monterotondo Campus International Development, CNR, Consiglio Nazionale delle Ricerche |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0156_3_A04. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Animals used for archiving | heterozygous C57BL/6NTac, wild-type C57BL/6NTac |
Stage of embryos | 2-cell |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Phakomatosis cesioflammea / Orphanet_79483
- Phakomatosis cesiomarmorata / Orphanet_79484
- Uveal melanoma / Orphanet_39044
- Familial hypocalciuric hypercalcemia type 2 / Orphanet_101049
- Autosomal dominant hypocalcemia / Orphanet_428
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased circulating phosphate level / IMPC
- decreased erythrocyte cell number / IMPC
- decreased hemoglobin content / IMPC
- decreased mean corpuscular volume / IMPC
- decreased bone mineral density / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating calcium level / IMPC
- increased startle reflex / IMPC
- increased red blood cell distribution width / IMPC
- vertebral fusion / IMPC
- decreased hematocrit / IMPC
- increased bone mineral content / IMPC
- abnormal behavior / IMPC
- decreased circulating triglyceride level / IMPC
- decreased circulating amylase level / IMPC
- thrombocytopenia / IMPC
MGI phenotypes (gene matching)
- increased foot pad pigmentation / MGI
- hyperpigmentation / MGI
- increased circulating triglyceride level / MGI
- hepatic steatosis / MGI
- nervous system phenotype / MGI
- darkened coat color / MGI
- decreased susceptibility to type I hypersensitivity reaction / MGI
- increased liver triglyceride level / MGI
- increased tail pigmentation / MGI
- increased ear pigmentation / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).